Want to Monitor Medicare's New Drug Benefit Program? Start by Sending a Check for $120,000
Medicare Part D is a bold experiment in the public/private provision of health insurance. Both researchers and beneficiaries need access to data to see if it works, but the government is stonewalling, according to Dana Goldman and Daniel McFadden.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
When requesting a correction, please mention this item's handle: RePEc:bpj:evoice:v:5:y:2008:i:4:n:1. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Peter Golla)
If references are entirely missing, you can add them using this form.